Commercialization Efforts definition

Commercialization Efforts shall have correlative meanings thereto.
Commercialization Efforts means efforts (a) to commercialize all Barbed Suture Products for the indications for which the requisite governmental approval, including FDA clearance, has been granted, (b) to develop and obtain the requisite governmental approval, including FDA clearance, of the orthopedic indication of a Barbed Suture Product for tendon repair and (c) to commercially exploit the Company’s existing Company Proprietary Rights.
Commercialization Efforts has the meaning described in Section 8.1.

Examples of Commercialization Efforts in a sentence

  • Funding Commitment(s) Part 3: Phase lIB Supplement Data Part 4: Products and/or Processes Part 5: Company Employment and Revenue Part 6: Company Commercialization Efforts The Phase II final report is due no later than 90 days after the end date of the grant.

  • Funding Commitment(s) Part 3: Phase lIB Supplement Data Part 4: Products and/or Processes Part 5: Company Employment and Revenue Part 6: Company Commercialization Efforts The Phase II final report is due no later than 90 days after the expiration of the award.

  • Funding Commitment(s) Part 3: Phase lIB Supplement Data Part 4: Products and/or Processes Part 5: Company Employment and Revenue Data Part 6: Company Commercialization Efforts The Phase II final report is due no later than 90 days after the expiration of the award.

  • Further, with respect to the Company's obligations under Section 704 (Reasonable Diligence) and Section 505 (Reports by Company Regarding Commercialization Efforts), the Trustee shall make such inquiries and obtain such evidence as a prudent business person would do under the circumstances in order to monitor and verify the Company's proper performance of the Company's obligations pursuant to said Sections 704 and 505.

  • SIGAR Audit 13-07, Afghanistan’s National Power Utility: Commercialization Efforts Challenged by Expiring Subsidy and Poor USFOR-A and USAID Project Management, April 18, 2013.

  • Licensee shall use Commercially Reasonable Efforts to Develop and Commercialize Licensed Products in the Field in the Territory in accordance with this Agreement (including Section 4.01 (Development in the Field in the Territory) and Section 6.04 (Commercialization Efforts)).

  • Stepp et al., “Turning the Page;” U.S. Department of Energy Office of Inspector General, “Audit Report: Technology Transfer and Commercialization Efforts at the Department of Energy’s National Laboratories (Washington, D.C.: DOE, 2014), 2; U.S. Government Accountability Office, “Clearer Priorities and Greater Use of Innovative Approaches Could Increase the Effectiveness of Energy Laboratories,” (Washington, D.C. GAO, 2009), 1.

  • Within 30 calendar days of the end of the second and fourth calendar quarters of each Earnout Year, Buyer shall deliver to the Stockholder Representative a report in reasonable detail setting forth for the preceding six calendar months, Product Revenues, Expenditures for Commercialization Efforts, Standard Income, Non-Standard Income and the status of FDA clearance for Barbed Suture Products in the field of tendon repair.

  • Phase lIB Supplement Data Part 4: Products and/or Processes Part 5: Company Employment and Revenue Part 6: Company Commercialization Efforts The Phase II final report is due no later than 90 days after the end date of the grant.

  • SIGAR Audit 13-7, Afghanistan’s National Power Utility: Commercialization Efforts Challenged by Expiring Subsidy and Poor USFOR-A and USAID Project Management, April 2013.

Related to Commercialization Efforts

  • Commercialization means any and all activities directed to the preparation for sale of, offering for sale of, or sale of a Product, including activities related to marketing, promoting, distributing, and importing such Product, and interacting with Regulatory Authorities regarding any of the foregoing. When used as a verb, “to Commercialize” and “Commercializing” means to engage in Commercialization, and “Commercialized” has a corresponding meaning.

  • Development Activities means any activity, including the discharge of dredged or fill material, which results directly in a more than de minimus change in the hydrologic regime, bottom contour, or the type, distribution or diversity of hydrophytic vegetation, or which impairs the flow, reach, or circulation of surface water within wetlands or other waters;

  • Commercializing means to engage in Commercialization and “Commercialized” has a corresponding meaning.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Commercialize means to engage in Commercialization.

  • Collaboration Product means any product that contains one or more Discovered RNAi Compound(s) as active ingredient(s).

  • Development Plan means that information and those requirements for a development set forth in section 16.

  • Commercialise means to promote, market, distribute and/or sell a Product and “Commercialising” and “Commercialisation” shall be construed accordingly;

  • Development Activity means any activity defined as Development which will necessitate a Floodplain Development Permit. This includes buildings, structures, and non-structural items, including (but not limited to) fill, bulkheads, piers, pools, docks, landings, ramps, and erosion control/stabilization measures.

  • Development Program means the implementation of the development plan.

  • Diligent Efforts means, with respect to the Product, efforts of a Person to carry out its obligations, and to cause its controlled Affiliates and Product licensees, if any, to carry out their respective obligations, using such efforts and employing such resources normally used by Persons in the pharmaceutical business similar in size and resources to Parent relating to seeking regulatory approval for a product candidate or commercialization of an approved product that is of similar market potential at a similar stage in its development or product life, taking into account issues of market exclusivity, product profile, including efficacy, safety, tolerability and convenience, the competitiveness of alternate products in the marketplace or under development, the availability of existing forms or dosages of the Product for other indications, the launch or sales of a generic or biosimilar product, the regulatory environment and the profitability of the Product (including pricing and reimbursement status) and other relevant considerations, including technical, commercial, legal, scientific and/or medical factors.

  • Commercialization Costs with respect to a Collaboration Product shall mean the direct variable costs and direct fixed costs incurred by Diacrin/Genzyme LLC with respect to work performed by the Parties and their Affiliates and subcontractors in connection with the conduct of the Commercialization Plan for such Collaboration Product, including without limitation sales and marketing costs related to performing market research, advertising, producing promotional literature, sponsoring seminars and symposia, originating sales and providing reimbursement and other patient support services. Direct variable costs shall be deemed to be the cost of labor, raw materials, supplies and other resources directly consumed in the conduct of the Commercialization Plan, as well as royalties payable to Third Parties, including royalties payable to Massachusetts General Hospital. Direct fixed costs shall be deemed to be the cost of facilities, utilities, insurance, equipment depreciation and other fixed costs directly related to the conduct of the Commercialization Plan, allocated based upon the proportion of such costs directly attributable to support of the Commercialization Plan or by such other method of cost allocation as may be approved by the Steering Committee. All cost determinations made hereunder shall be made in accordance with United States generally accepted accounting principles, consistently applied.

  • Joint Commercialization Committee or “JCC” means the committee formed by the Parties as described in Section 2.4.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Commercialized shall have corresponding meanings.

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Development Plans means a coherent set of operations defined and financed exclusively by the OCTs in the framework of their own policies and strategies of development, and those agreed upon between an OCT and the Member State to which it is linked;

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Clinical Studies means Xxxxx 0, Xxxxx 0, Xxxxx 0, Xxxxx 3, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such indication.

  • Collaboration Program means the conduct of both the Inhaled Collaboration and Vaccine Collaboration.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Research Program has the meaning set forth in Section 3.1.

  • Licensed Product means any product or part thereof which:

  • Development Candidate means a pre-clinical Licensed Product which possesses desirable properties of a therapeutic agent for the treatment of a clinical condition based on in vitro and animal proof-of-concept studies.

  • Medical Affairs Activities means activities designed to ensure or improve appropriate medical use of, conduct medical education of, or further research regarding, a Product sold in the Territory, including by way of example: (a) customary activities of medical science liaisons; (b) grants to support continuing medical education, symposia, or Third Party research related to a Product in the Territory; (c) development, publication and dissemination of publications relating to a Product in the Territory; (d) medical information services provided in response to inquiries communicated via sales representatives or received by letter, phone call or email; (e) conducting advisory board meetings or other consultant programs; and (f) establishment and implementation of risk, evaluation and mitigation and strategies (REMS); provided that, for purposes of cost allocation provisions under this Agreement, Medical Affairs Activities shall not include the conduct of Clinical Trials.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).